Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: June 30, 2021
Observational Study Evaluating Long-term Safety of Real-world Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: May 2021
aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 51
  • Start Date: April 2021
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 208
  • Start Date: April 1, 2021
Investigating the Sleeping Habits of Patients With Haemophilia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological
  • Participants: 12
  • Start Date: April 2021
Assessment of Safety and Preliminary Efficacy of ASC-618 in Subjects With Severe and Moderately Severe Hemophilia A
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 40
  • Start Date: April 1, 2021
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 55
  • Start Date: March 31, 2021
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: March 2021
Prospective, Single-Arm, Open-Label Use of Hemlibra (Emicizumab) in the Treatment of Mild Hemophilia A
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: March 1, 2021
Intensive Replacement Treatment in Haemophilia Patients With Synovitis
Showing 1-12 of 198